Clinical Trial Update: Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 trial evaluating ex vivo cultured allogeneic bone marrow-derived mesenchymal stem cells for acute myocardial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Allogeneic mesenchymal stem cells (bone marrow-derived, ex vivo cultured) (Mesenchymal stem cells)

Snippet

Sponsor: Stempeutics Research Pvt Ltd | Conditions: Myocardial Infarction | Phase 1, Phase 2 | Status: COMPLETED